Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SUNRUN INC. (RUN)

  • Business News
  • April 08, 2026, 12:00 UTC
  • 4
  • 1 comments

Sunrun Announces Date for First Quarter 2026 Earnings Report

Market reaction Comment Full text

ATKORE INC. (ATKR)

  • Business News
  • April 08, 2026, 12:00 UTC
  • 2
  • 1 comments

Atkore Inc. Announces Sale of HDPE Pipe & Conduit Business to Infra Pipes

Market reaction Comment Full text

FOR THE EARTH CORP. (FTEG)

  • Business News
  • April 08, 2026, 11:57 UTC
  • 3
  • 1 comments

Net Asset Value(s)

Market reaction Comment Full text

Encompass Health Corp (EHC)

  • Business News
  • April 08, 2026, 11:56 UTC
  • 3
  • 1 comments

Encompass Health Corporation - Encompass Health announces annual stockholder meeting date

Market reaction Comment Full text

ENCOMPASS HEALTH CORP (EHC)

  • Business News
  • April 08, 2026, 11:55 UTC
  • 3
  • 1 comments

Encompass Health announces annual stockholder meeting date

Market reaction Comment Full text

3 E NETWORK TECHNOLOGY GROUP LTD (MASK)

  • Business News
  • April 08, 2026, 11:50 UTC
  • 3
  • 1 comments

Nasdaq Determines That 3 E Network Has Regained Compliance with Continued Listing Requirements

Market reaction Comment Full text

CURANEX PHARMACEUTICALS INC (CURX)

  • Business News
  • April 08, 2026, 11:47 UTC
  • 5
  • 1 comments

Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline

Market reaction Comment Full text

NUBURU, INC. (BURU)

  • Business News
  • April 08, 2026, 11:45 UTC
  • 3
  • 1 comments

NUBURU Provides Corporate Update Highlighting Initial Revenue Traction and ~$6M+ Combined Pipeline Across Software and Directed-Energy Verticals

Market reaction Comment Full text

ROCKET LAB CORP (RKLB)

  • Business News
  • April 08, 2026, 11:30 UTC
  • 3
  • 1 comments

Rocket Lab Completes at the Market Offering

Market reaction Comment Full text

PLUS THERAPEUTICS, INC. (PSTV)

  • Business News
  • April 08, 2026, 11:30 UTC
  • 3
  • 1 comments

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas

Market reaction Comment Full text
  • Previous
  • 817
  • 818
  • 819
  • 820
  • 821
  • Next

Search

News categories

  • Technical Exchange News(12054)
  • Event(5289)
  • SEC News(250748)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150101)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin